In the rapidly advancing world of biotechnology, sterility testing remains a critical linchpin, particularly for Advanced Therapy Medicinal Products (ATMPs) such as cell therapies. The stakes are high: microbial contamination in these therapies poses not just a threat but potentially devastating consequences for patients. This crucial safeguarding process, however, has been hamstrung by time constraints, […]